A detailed history of Wells Fargo & Company transactions in Swk Holdings Corp stock. As of the latest transaction made, Wells Fargo & Company holds 1,712 shares of SWKH stock, worth $29,069. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,712
Previous 1,566 9.32%
Holding current value
$29,069
Previous $27,000 7.41%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$16.11 - $17.75 $2,352 - $2,591
146 Added 9.32%
1,712 $29,000
Q1 2024

May 10, 2024

BUY
$16.1 - $17.96 $2,704 - $3,017
168 Added 12.02%
1,566 $27,000
Q4 2023

Feb 09, 2024

BUY
$15.66 - $18.29 $3,194 - $3,731
204 Added 17.09%
1,398 $24,000
Q3 2023

Nov 13, 2023

SELL
$15.46 - $16.8 $3,710 - $4,032
-240 Reduced 16.74%
1,194 $18,000
Q2 2023

Aug 15, 2023

BUY
$16.5 - $17.95 $13,216 - $14,377
801 Added 126.54%
1,434 $24,000
Q1 2023

May 12, 2023

BUY
$17.59 - $19.42 $11,134 - $12,292
633 New
633 $11,000
Q3 2022

Nov 14, 2022

SELL
$16.25 - $18.73 $585 - $674
-36 Reduced 80.0%
9 $0
Q2 2022

Aug 12, 2022

BUY
$16.9 - $19.9 $405 - $477
24 Added 114.29%
45 $1,000
Q3 2021

Nov 15, 2021

SELL
$17.05 - $19.9 $1,040 - $1,213
-61 Reduced 74.39%
21 $0
Q2 2021

Aug 16, 2021

SELL
$14.95 - $17.8 $18,328 - $21,822
-1,226 Reduced 93.73%
82 $1,000
Q1 2021

May 13, 2021

SELL
$13.16 - $15.09 $11,278 - $12,932
-857 Reduced 39.58%
1,308 $19,000
Q4 2020

Feb 09, 2021

BUY
$12.92 - $15.29 $11,550 - $13,669
894 Added 70.34%
2,165 $31,000
Q3 2020

Nov 05, 2020

SELL
$11.74 - $14.5 $6,574 - $8,120
-560 Reduced 30.58%
1,271 $18,000
Q2 2020

Aug 13, 2020

BUY
$10.36 - $13.76 $18,969 - $25,194
1,831 New
1,831 $22,000

Others Institutions Holding SWKH

About SWK Holdings Corp


  • Ticker SWKH
  • Exchange NASDAQ
  • Sector Financial Services
  • Industry Asset Management
  • Shares Outstandng 12,828,700
  • Market Cap $218M
  • Description
  • SWK Holdings Corporation, a specialty finance company that focuses on the healthcare sector. It operates in two segments, Finance Receivables and Pharmaceutical Development. The company provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and r...
More about SWKH
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.